Psychedelics paired with therapy could treat chronic mental health conditions
Psychedelic drugs are mostly banned in Europe, but new research suggests they may be beneficial to some when taken in a controlled setting.
Oct 25, 2022
0
8
Psychedelic drugs are mostly banned in Europe, but new research suggests they may be beneficial to some when taken in a controlled setting.
Oct 25, 2022
0
8
For the Laudick family of Greensburg, Indiana, life forever changed on Aug. 5, 2013. That was the day four-year-old Leah Laudick told her mom, Shelly, that she had a bad headache.
Oct 24, 2022
0
10
A study published today in the journal GigaScience provides an enormous amount of behavioral data, presented in a detailed videographic virtual library, that was used to explore obsessive-compulsive disorder (OCD) in an animal ...
Oct 20, 2022
0
6
Clinical trials are most likely to establish a causal relationship and attribute the benefits observed in the outcomes to the treatments. Effective data sharing and re-use of completed trial data can advance science and improve ...
Oct 20, 2022
0
11
In the early stages of the COVID-19 pandemic, the coronavirus was everywhere—stuck to our cellphone screens, smeared on our mail, dangling from doorknobs, even clinging to our cereal boxes. Except that it wasn't.
Sep 26, 2022
1
20
A powerful new genome editing technique is enabling researchers to replicate human diseases with unprecedented accuracy, promising to revolutionize the drug discovery process for a range of cancers.
Sep 21, 2022
0
95
The Laboratory of Neuroimmunology of the Institute of Experimental Medicine, Budapest (IEM), Hungary, led by Ádám Dénes, describes the presence of a direct interaction site between microglial cells and the cell body of ...
Sep 20, 2022
0
77
Science depends on the cleanest, most complete and most recent data possible when it comes to analyzing the effectiveness of political and social measures in the fight against the Corona pandemic. In a joint editorial article ...
Sep 19, 2022
0
5
Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
Long-lasting immune cells that specifically recognize the SARS-CoV-2 virus were found in the noses of people who were infected following vaccination. These virus-specific T cells, which were not present in those who had only ...
Sep 9, 2022
0
57